SCIENION and Anteo Partner
News Jul 25, 2015
SCIENION and Australian biotech company Anteo Technologies have announced that they have partnered to co-develop protein microarray consumables using Anteo’s proprietary Mix&Go™ technology. Mix&Go activated surface consumables improve functionality and stability of biological molecules.
The project will combine the advantages of the Mix&Go technology with the capability of SCIENION’s precision spotting sciFLEXARRAYER technology, with the objective of delivering more accurate results and better, longer-lasting and more cost effective diagnostics. The first targeted products of the Anteo and SCIENION collaboration will be activated glass and polymer slides.
Josh Soldo, VP Scientific Affairs at Anteo explains: “With SCIENION, we have found a partner with deep expertise in surface functionalization and protein spotting, and one with excellent products. As a result of our partnership, scientists will soon have the tools that they need to overcome the present limitations of protein arrays, and increase the performance of their arrays, while reducing the sample size needed to get results. In brief, we expect the partnership to yield more effective tests with better specificity.”
Holger Eickhoff, CEO of SCIENION, says: “As a very customer focused company, we always seek to expand the portfolio of solutions we can propose to help implement the various platform technologies that our customers bring to us. Anteo’s new coating technology will enable us to provide an even higher level of customer application support via unprecedented combinations of materials, surfaces and deposition technology. The perfect pairing of the right surface with the right dispensing is key to a successful application where a biological molecule is deposited to become attached to a surface. The expertise of both companies is very complementary, and together we will exploit the resulting synergies.”
Both SCIENION and Anteo will be in attendance at the AACC Annual Meeting and Clinical Lab Expo in Atlanta, GA, USA from July 26-30, 2015.
Computation and Chemistry Combine to Create World-First Auxetic ProteinNews
A team of chemists at the University of California, San Diego (UCSD) has now designed a two-dimensional protein crystal that toggles between states of varying porosity and density. This is a first in biomolecular design that combined experimental studies with computation done on supercomputers. The research, published in April 2018 in Nature Chemistry, could help create new materials for renewable energy, medicine, water purification, and more.
Fructose Formula Poses Risk to Babies With Metabolic DisorderNews
Babies with inherited intolerance of fructose face a risk of acute liver failure if they are fed certain widely available formulas containing fructose, pediatricians and geneticists are warning. Baby formula manufacturers should remove fructose or sucrose, or explicitly label their products to allow parents to avoid those sweeteners if necessary, the doctors say.